Cargando…

Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure

Abnormal invasion of placenta or placenta accreta spectrum disorders refer to the penetration of the trophoblastic tissue through the decidua basalis into the underlying uterine myometrium, the uterine serosa or even beyond, extending to pelvic organs. It is classified depending on the degree of inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñas Carrillo, Ana, Chandraharan, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777059/
https://www.ncbi.nlm.nih.gov/pubmed/31578123
http://dx.doi.org/10.1177/1745506519878081
_version_ 1783456558720483328
author Piñas Carrillo, Ana
Chandraharan, Edwin
author_facet Piñas Carrillo, Ana
Chandraharan, Edwin
author_sort Piñas Carrillo, Ana
collection PubMed
description Abnormal invasion of placenta or placenta accreta spectrum disorders refer to the penetration of the trophoblastic tissue through the decidua basalis into the underlying uterine myometrium, the uterine serosa or even beyond, extending to pelvic organs. It is classified depending on the degree of invasion into placenta accreta (invasion <50% of the myometrium), increta (invasion >50% of the myometrium) and percreta (invading the serosa and adjacent pelvic organs). Clinical diagnosis is made intra-operatively; however, the confirmative diagnosis can only be made after a histopathological examination. The incidence of abnormal invasion of placenta has increased worldwide, mostly as a consequence of the rise in caesarean section rates, from 1 in 2500 pregnancies to 1 in 500 pregnancies. The importance of the disease is due to the increased maternal and foetal morbidity and mortality. Foetal implications are mainly due to iatrogenic prematurity, while maternal implications are mostly the increased risk of obstetric haemorrhage and surgical complications. The average blood loss is 3000–5000 mL, and up to 90% of the patients require a blood transfusion. An accurate and timely antenatal diagnosis is essential to improve outcomes. The traditional management of abnormal invasion of placenta has been a peripartum hysterectomy; however, the increased incidence and the short- and long-term consequences of a radical approach have led to the development of more conservative techniques, such as the intentional retention of the placenta, partial myometrial excision and the ‘Triple P procedure’. Irrespective of the surgical technique of choice, women with a high suspicion or confirmed abnormally invasive placenta should be managed in a specialist centre with surgical expertise with a multi-disciplinary team who is experienced in managing these complex cases with an immediate availability of blood products, interventional radiology service, an intensive care unit and a neonatal intensive care unit to optimize the outcomes.
format Online
Article
Text
id pubmed-6777059
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-67770592019-10-16 Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure Piñas Carrillo, Ana Chandraharan, Edwin Womens Health (Lond) Review Abnormal invasion of placenta or placenta accreta spectrum disorders refer to the penetration of the trophoblastic tissue through the decidua basalis into the underlying uterine myometrium, the uterine serosa or even beyond, extending to pelvic organs. It is classified depending on the degree of invasion into placenta accreta (invasion <50% of the myometrium), increta (invasion >50% of the myometrium) and percreta (invading the serosa and adjacent pelvic organs). Clinical diagnosis is made intra-operatively; however, the confirmative diagnosis can only be made after a histopathological examination. The incidence of abnormal invasion of placenta has increased worldwide, mostly as a consequence of the rise in caesarean section rates, from 1 in 2500 pregnancies to 1 in 500 pregnancies. The importance of the disease is due to the increased maternal and foetal morbidity and mortality. Foetal implications are mainly due to iatrogenic prematurity, while maternal implications are mostly the increased risk of obstetric haemorrhage and surgical complications. The average blood loss is 3000–5000 mL, and up to 90% of the patients require a blood transfusion. An accurate and timely antenatal diagnosis is essential to improve outcomes. The traditional management of abnormal invasion of placenta has been a peripartum hysterectomy; however, the increased incidence and the short- and long-term consequences of a radical approach have led to the development of more conservative techniques, such as the intentional retention of the placenta, partial myometrial excision and the ‘Triple P procedure’. Irrespective of the surgical technique of choice, women with a high suspicion or confirmed abnormally invasive placenta should be managed in a specialist centre with surgical expertise with a multi-disciplinary team who is experienced in managing these complex cases with an immediate availability of blood products, interventional radiology service, an intensive care unit and a neonatal intensive care unit to optimize the outcomes. SAGE Publications 2019-10-03 /pmc/articles/PMC6777059/ /pubmed/31578123 http://dx.doi.org/10.1177/1745506519878081 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Piñas Carrillo, Ana
Chandraharan, Edwin
Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure
title Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure
title_full Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure
title_fullStr Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure
title_full_unstemmed Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure
title_short Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure
title_sort placenta accreta spectrum: risk factors, diagnosis and management with special reference to the triple p procedure
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777059/
https://www.ncbi.nlm.nih.gov/pubmed/31578123
http://dx.doi.org/10.1177/1745506519878081
work_keys_str_mv AT pinascarrilloana placentaaccretaspectrumriskfactorsdiagnosisandmanagementwithspecialreferencetothetriplepprocedure
AT chandraharanedwin placentaaccretaspectrumriskfactorsdiagnosisandmanagementwithspecialreferencetothetriplepprocedure